Patient Experience With HR+/HER2- EBC
A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

Released: December 13, 2022

Expiration: December 12, 2023

Zoe Lanham
Zoe Lanham,

Activity

Progress
1
Course Completed

In this episode, Zoe Lanham, a woman with high-risk hormone receptor–positive/HER2-negative early breast cancer, discusses the importance of effective communication between patients and their healthcare team, drawing on her personal experience.